Jul 24, 2021 4:19 AM
BACK TO TOP
KSE100
47,793.07
-80.19
(-0.17%)
ALLSHR
32,627.84
-7.30
(-0.02%)
KSE30
19,161.24
-31.94
(-0.17%)
KMI30
77,633.54
-108.65
(-0.14%)
BKTi
12,738.08
-13.46
(-0.11%)
OGTi
12,530.80
-6.03
(-0.05%)
KMIALLSHR
23,421.63
-15.93
(-0.07%)
UPP9
13,261.26
-3.64
(-0.03%)
NITPGI
9,803.84
-4.22
(-0.04%)
NBPPGI
11,875.10
-6.86
(-0.06%)
MZNPI
11,329.15
-38.06
(-0.33%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.166.48
0.55
(0.33%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jul 23, 2021 5:00 PM
REG
FUT
ODL
Open
168.99
High
169.13
Low
163.80
Volume
218,300
CIRCUIT BREAKER
153.49 — 178.37
DAY RANGE
163.80 — 169.13
52-WEEK RANGE
145.00 — 199.70
Ask Price
0.00
Ask Volume
0
Bid Price
166.48
Bid Volume
2,500
LDCP
165.93
VAR
10.00
HAIRCUT
22.50
P/E Ratio (TTM) **
14.43
1-Year Change *
-12.33%
YTD Change *
-13.21%
Open
164.01
High
167.00
Low
164.01
Close
167.00
Change
0.64%
LDCP
165.93
Volume
3
Total Trades
2
CIRCUIT BREAKER
149.34 — 182.52
DAY RANGE
164.01 — 167.00
Ask Price
166.00
Ask Volume
50
Bid Price
164.04
Bid Volume
9
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Ms. Erum Shakir RahimCEO
Mr. Dmytro OliinykChairman
Ms. Mehar-e-daraksha AmeerCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
53,018,432.44
Shares
318,467,278
Free Float
51,912,872
Free Float
16.30%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
May 17, 2021CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 View   PDF
Apr 30, 2021Transmission of Quarterly Report for the Period Ended 2021-03-31 View   PDF
Apr 28, 2021Financial Results for the Quarter ended March 31, 2021 View   PDF
Apr 6, 2021Transmission of Annual Report for the Year Ended 2020-12-31 View   PDF
Mar 10, 2021Financial Results for the Year Ended December 31, 2020 View   PDF
Nov 2, 2020Transmission of Quarterly Report for the Period Ended September 30, 2020 View   PDF
Oct 28, 2020Financial Results for the Quarter ended September 30, 2020 View   PDF
Aug 31, 2020Transmission of Quarterly Report for the Period Ended 2020-06-30 View   PDF
Aug 24, 2020Financial Results for the Quarter ended June 30, 2020 View   PDF
May 28, 2020Transmission of Quarterly Report for the Period Ended 2020-03-31 View   PDF
DateTitleDocument
Apr 27, 2021MEETING IN PROGRESS View   PDF
Apr 20, 2021Board of Directors Meeting View   PDF
Apr 6, 2021Notice of Annual General Meeting View   PDF
Apr 6, 2021Notice of Annual General Meeting View   PDF
Apr 5, 2021PRIOR PUBLICATION NOTICE OF ANNUAL GENERAL MEETING View   PDF
Mar 2, 2021Board of Directors Meeting View   PDF
Jan 8, 2021Board Meeting Other than Financial Results View   PDF
Jan 8, 2021Board Meeting Other than Financial Results View   PDF
Oct 21, 2020Board of Directors Meeting View   PDF
Aug 17, 2020Board of Directors Meeting View   PDF
DateTitleDocument
Jun 1, 2021Appointment of Chief Financial Officer and Executive Director View   PDF
May 4, 2021PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
Apr 27, 2021CERTIFIED TRUE COPY OF RESOLUTION View   PDF
Mar 31, 2021Material Information View   PDF
Mar 9, 2021GLAXO | GlaxoSmithKline Pakistan Limited PDF
Jan 1, 2021Change of the Company Secretary View   PDF
Jan 1, 2021CHANGE OF THE COMPANY SECRETARY View   PDF
Dec 1, 2020 Corporate Briefing Session View   PDF
Nov 24, 2020Change in Particular of Auditors View   PDF
Nov 5, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales35,090,11236,581,74934,006,84032,773,770
Profit after Taxation3,375,2403,041,1233,257,9512,981,023
EPS10.609.5510.239.36
Q1 2021Q3 2020Q2 2020Q1 2020
Sales7,693,50910,812,7097,738,3938,033,916
Profit after Taxation725,5471,126,141817,784425,564
EPS2.283.542.571.34
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)21.4721.0824.7426.48
Net Profit Margin (%)9.628.319.589.10
EPS Growth (%)10.99(6.65)9.297.83
PEG1.65(2.53)1.192.29

Payouts

DateFinancial ResultsDetailsBook Closure
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports